Eagle Pharmaceuticals
EGRX
#10440
Rank
ยฃ3.31 M
Marketcap
ยฃ0.26
Share price
0.00%
Change (1 day)
-60.70%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: ยฃ3.31 Million

As of February 2026 Eagle Pharmaceuticals has a market cap of ยฃ3.31 Million. This makes Eagle Pharmaceuticals the world's 10440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ3.31 M-23.46%
2025ยฃ4.32 M-23.76%
2024ยฃ5.67 M-89.35%
2023ยฃ53.31 M-83.05%
2022ยฃ0.31 B-35.45%
2021ยฃ0.48 B9.43%
2020ยฃ0.44 B-28.71%
2019ยฃ0.62 B41.4%
2018ยฃ0.44 B-25.12%
2017ยฃ0.58 B-40.73%
2016ยฃ0.99 B6.36%
2015ยฃ0.93 B569.51%
2014ยฃ0.13 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
ยฃ3.31 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ400.07 B 12,071,930.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ208.46 B 6,290,134.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ679.39 B 20,500,064.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ134.52 B 4,059,004.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ81.89 B 2,470,877.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ76.20 B 2,299,288.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ28.57 B 861,997.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel